State Street Corporation 13D and 13G filings for Sorrento Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-10 11:21 am Sale |
2023-02-28 | 13G | Sorrento Therapeutics, Inc. SRNE |
STATE STREET CORP STT |
156,800 0.030% |
-50,480,771 (-99.69%) |
Filing |
| 2023-02-09 3:48 pm Purchase |
2022-12-31 | 13G | Sorrento Therapeutics, Inc. SRNE |
STATE STREET CORP STT |
50,637,571 10.730% |
10,976,472 (+27.68%) |
Filing |
| 2022-07-11 11:38 am Purchase |
2022-06-30 | 13G | Sorrento Therapeutics, Inc. SRNE |
STATE STREET CORP STT |
39,661,099 10.200% |
39,661,099 (New Position) |
Filing |